Table 2.
Long-Term Follow-Up of the EORTC-NCIC Trial4.
| Survival (%) |
||||
|---|---|---|---|---|
| Treatment | 2-year | 3-year | 4-year | 5-year |
| RT | 10.9 | 4.4 | 3.0 | 1.9 |
| RT + TMZ | 27.2 | 16.0 | 12.1 | 9.8 |
Abbreviations: EORTC-NCIC, European Organisation for Research and Treatment of Cancer-National Cancer Institute of Canada; RT, radiation therapy; TMZ, temozolomide.